Exploring polyamine interactions and binding pockets in SARS-CoV-2 ORF3a.

Area of Science:

• Virology
• Drug Discovery
• Computational Biology

Background:

• The COVID-19 pandemic necessitates the development of effective vaccines and treatments.
• The SARS-CoV-2 Open Reading Frame 3a (ORF3a) protein is a key viral component and a potential therapeutic target.
• Aliphatic polyamines (putrescine, spermidine, spermine) are being investigated for their potential to inhibit ORF3a activity.

Purpose of the Study:

• To explore the binding interactions of polyamines with the SARS-CoV-2 ORF3a protein using computational methods.
• To identify potential binding sites on ORF3a for polyamine molecules.
• To assess the stability of polyamine-ORF3a complexes for therapeutic drug design.

Main Methods:

• Pocket prediction and molecular docking (blind and site-specific) were employed to identify potential binding sites.
• Molecular dynamics (MD) simulations were used to analyze the stability and interactions of polyamine-ORF3a complexes.
• Ligand flooding simulations were conducted to further investigate binding characteristics.

Main Results:

• Computational analyses identified specific binding sites for polyamines at the tip of the ORF3a cytoplasmic domain and within the transmembrane domain's upper tunnel.
• MD simulations demonstrated the stable binding of spermidine within the upper tunnel pocket of ORF3a.
• Key interactions, including salt bridges and hydrogen bonds, were observed between spermidine's amine groups and negatively charged ORF3a residues.

Conclusions:

• Polyamines, particularly spermidine, can bind effectively to specific sites on the SARS-CoV-2 ORF3a protein.
• The identified binding interactions provide a foundation for designing novel therapeutic agents targeting ORF3a for COVID-19 treatment.
• These findings highlight a promising avenue for developing new drugs against SARS-CoV-2.